he cardiac sympathetic nerve system has been evaluated with the low-frequency power (LF) of heart rate variability (HRV) 1 and cardiac 123 Imetaiodobenzylguanidine (MIBG) washout. 2 Recently, Somsen et al reported that the cardiac MIBG washout rate positively correlated with normalized LF in mild to moderate congestive heart failure (CHF), 3 which is contrary to our earlier finding; 4 that is, an inverse correlation of the MIBG washout rate with HRV including LF in various disorders. Furthermore, the normalized LF of their CHF patients [34.9±7%, mean (SD)] was lower than normal values (54±4%) despite a similar MIBG washout rate (7.7±8.4% vs 6.5±5.3%). 3 We therefore re-examined the correlation between MIBG and HRV in CHF.
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Methods
The patient group comprised 20 stable CHF patients (age, 49±15 years; female/male, 6/14) who underwent MIBG scintigraphy and 24-h ambulatory electrocardiography within 1 week and who had neither diabetes mellitus nor frequent arrhythmia. The control group comprised 11 age-and gender-matched normal subjects. The following MIBG and HRV studies were performed as a routine clinical examination in the patient group, while informed consent was obtained in the control group.
On the early and late anterior images obtained 15 min and 150 min after MIBG injection, respectively, mean MIBG activities per pixel were measured over the heart (H), background (BG) around the heart, and upper mediastinum (M). 2, 4 Heart-to-mediastinum activity ratio (H/M) was calculated in the early and late images, and the cardiac MIBG washout rate (%) was calculated with the formula:
Blood samples were obtained via an indwelling catheter in the forearm vein to measure plasma norepinephrine (pNE) levels, immediately before MIBG administration (from 9.00 to 11.00 h), while the patients were lying at rest. The pNE levels (pg/ml) were determined by high-performance liquid chromatography.
Ambulatory 24-h electrocardiograms were recorded; the time series of normal RR intervals for 24 h was analyzed with a fast Fourier transform algorithm; and LF (0.04-0.15 Hz), high-frequency (HF) power (0.15-0.40 Hz,), total power (TP), and normalized LF (LF/TP) were computed using a Marquette HRV program. 4 We also calculated 2 time-domain measures: 24-h SD of normal RR intervals (SDNN) and the percentage of differences between adjacent normal RR intervals >50 msec (pNN50).
All measures were expressed as mean ± SD. Differences between groups were examined by the Student's t-test. Correlations were expressed as Pearson correlation coefficients. Logarithm transformation was used before analysis of some variables to make them normally distributed. Statistical significance was defined as p<0.05. Table 1 shows the comparison between controls and CHF patients. The cardiac MIBG washout rate was significantly higher, early and late H/M were significantly lower, and all HRV measures including LF/TP were significantly lower in the 20 patients than in the 11 controls. In the total 31 subjects, the MIBG washout rate correlated inversely with SDNN (r=-0.57, p<0.001), ln [ 
Results
H/M correlated with ln[HF] and pNN50 (r=0.70, 0.67, 0.71; p<0.05), but no other significant correlation was found
Discussion
We demonstrated enhanced cardiac MIBG washout and diminished HRV including LF and LF/TP in CHF patients, which is compatible with earlier reports. [5] [6] [7] [8] The absence of significant correlation between LF/TP and cardiac MIBG washout in our CHF patients, however, is not consistent with the results of Somsen et al, 3 which may be due to several differences between our and their studies. First, background subtraction was applied to the calculation of MIBG washout rate in our study but not in theirs. Second, pNE was not increased in all their patients (276±84 pg/ml) but was high in some of ours (63-3130, 792±640 pg/ml). However, these differences may not be significant, because there was no correlation (r=0.04; p=0.92) between LF/TP and the MIBG washout rate without background subtraction in our 8 patients without increased pNE. Third, a difference in severity of CHF, which was suggested by the difference in pNE level, may be involved in the presence or absence of a correlation between LF/TP and the cardiac MIBG washout, because LF may be markedly diminished in patients with severe CHF but not in those with mild CHF. 6, 8 Lastly, the positive correlation observed by Somsen et al 3 depended on only 2 of 10 patients and, therefore, might be purely coincidental.
In CHF, as shown in previous studies, 3,5-9 HRV including LF/TP may decrease while cardiac MIBG washout rate may increase. An inverse correlation is therefore inferred between the LF/TP and MIBG washout rate in the controls and CHF patients. In contrast, we showed a lack of correlation between the MIBG washout rate and HRV including LF/TP within the CHF patients, suggesting that HRV and MIBG measures may not similarly change in proportion to the severity of cardiac autonomic dysfunction in CHF. 6, 8 Moreover, the LF (or LF/TP) of HRV may not be an appropriate measure of cardiac sympathetic nerve activity, although it may have prognostic value in CHF patients. Thus, using MIBG we can approach cardiac sympathetic nerve system abnormalities in CHF from a different aspect than HRV.
